The decline of the estimated glomerular filtration rate (eGFR) and the presence of albuminuria are the typical hallmarks of kidney disease arising as one of the most frequent diabetic complications over a long period of time, generally known as diabetic nephropathy or diabetes kidney disease (DKD). However, a decline in the renal function may occur in diabetic patients for other reasons unrelated to glycemic control, and this condition is known as non-diabetic kidney disease (NDKD). In this opinion paper we will review these conditions, and we outline the importance of other investigations, such as kidney biopsy and the measurement of novel biomarkers, in order to identify the disease progression early, and to allow a timely intervention. We will also focus on the actual limits of the quantitative measurements of albumin in urine, especially with regards to potential interferences due to the treatment of patients with statins.

Re-thinking diabetic nephropathy: Microalbuminuria is just a piece of the diagnostic puzzle / D. Ceccarelli Ceccarelli, R. Paleari, B. Solerte, A. Mosca. - In: CLINICA CHIMICA ACTA. - ISSN 0009-8981. - 524:(2022 Jan 01), pp. 146-153. [10.1016/j.cca.2021.11.009]

Re-thinking diabetic nephropathy: Microalbuminuria is just a piece of the diagnostic puzzle

R. Paleari
Secondo
;
A. Mosca
Ultimo
2022

Abstract

The decline of the estimated glomerular filtration rate (eGFR) and the presence of albuminuria are the typical hallmarks of kidney disease arising as one of the most frequent diabetic complications over a long period of time, generally known as diabetic nephropathy or diabetes kidney disease (DKD). However, a decline in the renal function may occur in diabetic patients for other reasons unrelated to glycemic control, and this condition is known as non-diabetic kidney disease (NDKD). In this opinion paper we will review these conditions, and we outline the importance of other investigations, such as kidney biopsy and the measurement of novel biomarkers, in order to identify the disease progression early, and to allow a timely intervention. We will also focus on the actual limits of the quantitative measurements of albumin in urine, especially with regards to potential interferences due to the treatment of patients with statins.
Albuminuria; Diabetes; Kidney disease; Statins; Albuminuria; Humans; Diabetes Mellitus; Diabetic Nephropathies;
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
1-gen-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
A_60_2022_nefropatia_CCA.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.46 MB
Formato Adobe PDF
1.46 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/905414
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact